Journal of Minimal Access Surgery

ORIGINAL ARTICLE
[View FULLTEXT] [Download PDF]
Year : 2016  |  Volume : 12  |  Issue : 4  |  Page : 334--337

Laparoscopic splenic artery ligation for hypersplenism in cirrhosis: A case series

Hirdaya H Nag, Sandip Chandrasekar, John M Manipadum, Bettageri G Vageesh 
 Department of Gastrointestinal Surgery, Govind Ballabh Pant Institute of Postgraduate Medical Education and Research, New Delhi, India

Correspondence Address:
Hirdaya H Nag
Room No. 220, Academic Block, Department of GI surgery, G B Pant Institute of Postgraduate Medical Education and Research, New Delhi - 110 002
India

Background: Splenectomy for the treatment of hypersplenism in patients with cirrhosis (HIC) is related with complications. Laparoscopic splenic artery ligation (LSAL) may be an alternative treatment option. Aims: To evaluate safety and feasibility of LSAL in the treatment of HIC. Patients and Methods: Retrospective analysis of prospectively collected data of ten patients with HIC who were treated with LSAL from October 2012 to February 2015. Results: The median (range) age was 33.2 (13-56) years and sex distribution was equal. The median (range) leukocyte counts (×109/L) before, and at 3, 6 and 12 months after LSAL were 2.2 (0.8-8.2) and 5.65 (2.78-10.7), 4.7 (2.8-7.8) and 4.95 (3.4-7.7) respectively. The median (range) platelet counts (×109/L) before and at 3, 6 and 12 months after LSAL were 25.5 (11-65) and 75 (39-289), 74 (32-184) and 76 (56-251) respectively. Following LSAL, there was a significant improvement in total leucocyte count, platelet count and Model for End-Stage Liver Disease (MELD) score (P < 0.05). Two patients (20%) developed intraoperative bleeding and required conversion; one of these two patients developed splenic cyst that required radiological intervention. Four patients (40%) had post ligation syndrome (PLS) that was managed conservatively. During a median (range) follow-up of 19.5 (5-29) months, one patient (10%) required splenectomy due to inadequate response. Conclusion: LSAL is a safe and feasible treatment option for the palliation of symptomatic HIC, however, further prospective trials are necessary for confirmation.


How to cite this article:
Nag HH, Chandrasekar S, Manipadum JM, Vageesh BG. Laparoscopic splenic artery ligation for hypersplenism in cirrhosis: A case series.J Min Access Surg 2016;12:334-337


How to cite this URL:
Nag HH, Chandrasekar S, Manipadum JM, Vageesh BG. Laparoscopic splenic artery ligation for hypersplenism in cirrhosis: A case series. J Min Access Surg [serial online] 2016 [cited 2022 Jul 4 ];12:334-337
Available from: https://www.journalofmas.com/article.asp?issn=0972-9941;year=2016;volume=12;issue=4;spage=334;epage=337;aulast=Nag;type=0